Metformin: update on mechanisms of action on liver diseases

Substantial attention has been paid to the various effects of metformin on liver diseases; the liver is the targeted organ where metformin exerts its antihyperglycemic properties. In non-alcoholic fatty liver disease (NAFLD), studies have shown that metformin affects the ATP/AMP ratio to activate AM...

Descrición completa

Detalles Bibliográficos

Principais autores:	Gaoyi Ruan, Fangquan Wu, Dibang Shi, Hongxia Sun, Fangyan Wang, Changlong Xu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Nutrition
Assuntos:	non-alcoholic liver disease metformin cirrhosis AMPK pathway drug-induced liver injury
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fnut.2023.1327814/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!